LUCICEBTIDE

UNII:	CT77XS2YLT
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LUCICEBTIDE
GSRS Full Record:	CT77XS2YLT i

2407100-74-5
C/EBP Beta Antagonist ST101
D-Arginine, D-valyl-D-alanyl-D-α-glutamyl-D-alanyl-D-arginyl-D-α-glutamyl-D-α-glutamyl-D-leucyl-D-α-glutamyl-D-arginyl-D-leucyl-D-α-glutamyl-D-alanyl-D-arginyl-D-leucylglycyl-D-glutaminyl-D-alanyl-D-arginylglycyl-D-α-glutamyl-D-leucyl-D-lysyl-D-lysyl-D-tryptophyl-D-lysyl-D-methionyl-D-arginyl-D-arginyl-D-asparaginyl-D-glutaminyl-D-phenylalanyl-D-tryptophyl-D-leucyl-D-lysyl-D-leucyl-D-glutaminyl-
LUCICEBTIDE [USAN]
Lucicebtide
Lucicebtide [WHO-DD]
ST-101 (antineoplastic)
lucicebtide [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LUCICEBTIDE

Synonyms and Mappings

Resources